Given the wide spectrum of unique characteristics of macular neovascularization type 3 (MNV3) compared with types 1 and 2, we suggest regrading the colour photography assessment of the AREDS study to verify the impact of AREDS supplements on eyes with MNV3.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275938 | PMC |
http://dx.doi.org/10.1038/s41433-022-02249-2 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!